The latest attempt to restrict access to Mifepristone, one of two drugs used for  medication abortion, has been squashed by the Supreme Court in a unanimous decision. The court determined that the doctors who brought this case did not have legal standing or connection to the Food and Drug Administration (FDA) to challenge the drug’s approval. Medication abortion accounts for over 60% of abortions in the U.S. This ruling is a victory for women’s reproductive rights, but there are greater challenges to come.